Mirum Pharmaceuticals (MIRM) Times Interest Earned (2020 - 2026)
Mirum Pharmaceuticals (MIRM) recorded quarterly Times Interest Earned of -$218.33 in Q1 2026, down 17100.24% quarter-over-quarter from -$1.27 in Q4 2025, and down 5070.9% on a YoY basis from $4.39 in Q1 2025.
Mirum Pharmaceuticals (MIRM) Times Interest Earned (2020 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Times Interest Earned history runs 7 years deep, the most recent figure standing at -$218.33 for Q1 2026.
- In Q1 2026, Times Interest Earned fell 5070.9% year-over-year to -$218.33; the TTM figure through Mar 2026 stood at -$55.27 (down 937.79% YoY), while the FY2025 annual figure was -$1.54, up 74.87% from the prior year.
- Times Interest Earned was -$218.33 for Q1 2026 at Mirum Pharmaceuticals, down from -$1.27 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $0.72 in Q3 2025 to a low of -$218.33 in Q1 2026.
- Historically, Times Interest Earned has averaged -$18.29 across 5 years, with a median of -$6.79 in 2024.
- The sharpest annual moves came in 2025 and 2026: Times Interest Earned jumped 120.41% in 2025, then sank 5070.9% in 2026.
- A 5-year view of Times Interest Earned shows it stood at -$7.84 in 2022, then declined by 16.7% to -$9.15 in 2023, then gained by 26.0% to -$6.77 in 2024, then soared by 81.24% to -$1.27 in 2025, then sank by 17100.24% to -$218.33 in 2026.
- The last three Times Interest Earned figures came in at -$218.33 (Q1 2026), -$1.27 (Q4 2025), and $0.72 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Mirum Pharmaceuticals | 6.29 Bn | 5.90 Bn | 131.08 Mn | -218.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -218.33 |
| Dec 31, 2025 | -1.27 |
| Sep 30, 2025 | 0.72 |
| Jun 30, 2025 | -1.39 |
| Mar 31, 2025 | -4.22 |
| Dec 31, 2024 | -6.77 |
| Sep 30, 2024 | -3.54 |
| Jun 30, 2024 | -6.79 |
| Mar 31, 2024 | -7.40 |
| Dec 31, 2023 | -9.15 |
| Sep 30, 2023 | -7.04 |
| Jun 30, 2023 | -6.51 |
| Mar 31, 2023 | -6.40 |
| Dec 31, 2022 | -7.84 |
| Sep 30, 2022 | -8.28 |
| Jun 30, 2022 | -8.11 |
| Mar 31, 2022 | -8.67 |
| Dec 31, 2021 | -12.10 |
| Sep 30, 2021 | -7.56 |
| Jun 30, 2021 | -7.83 |